<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04152642</url>
  </required_header>
  <id_info>
    <org_study_id>CSD2019138</org_study_id>
    <nct_id>NCT04152642</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse</brief_title>
  <official_title>A Pilot Clinical Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse Compared to a Negative Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Procter and Gamble</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Procter and Gamble</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study is to determine if an experimental mouth rinse and a&#xD;
      marketed dry mouth rinse are more effective in relieving dry mouth compared to water.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a controlled, randomized, 3-treatment, 3-period crossover study in subjects with&#xD;
      self-reported dry mouth symptoms as determined by subject responses (as determined by the&#xD;
      response to &quot;relieving the discomfort of dry mouth&quot; question from the modified Product&#xD;
      Performance and Attributes Questionnaire I/ Moisturization and Dryness (PPAQ I/ MD)) compared&#xD;
      to water. Subjects enrollment is based on the responses to the Dry Mouth Inventory (DMI). A&#xD;
      sufficient number of volunteers will be screened to ensure enrollment of up to 30 subjects at&#xD;
      Acclimation. Subjects who meet the eligibility criteria will continue into the treatment&#xD;
      phase of the study. Safety will be assessed by Oral examinations at Baseline/Day1 and Day 4.&#xD;
      Subjects will complete questionnaires at Baseline (before product use Day 1 only), after&#xD;
      immediate use, 30 minutes, 1 hour, 2 hours, and 4 hours after supervised product use on Day 1&#xD;
      and Day 4 of each period. The PPAQ II questionnaire will be completed in the morning of Day 4&#xD;
      of each period. Subjects will be randomly assigned to treatment sequences at the Baseline&#xD;
      visit of Period 1. The treatment and washout periods will be repeated until all three&#xD;
      treatment periods have been completed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 4, 2019</start_date>
  <completion_date type="Actual">December 5, 2019</completion_date>
  <primary_completion_date type="Actual">December 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>3-treatment crossover, with 4 days of use</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Product Performance and Attributes (PPAQ I) Question #1: 2-hr at Day 4</measure>
    <time_frame>2-hour, Day 4</time_frame>
    <description>Product Performance and Attributes (PPAQ I) Question #1:&#xD;
Since you have been used the product, please rate each of the following at this timepoint: (Select one response for each attribute)- excellent=5, very good=4, good=3, fair=2, poor=1:&#xD;
1) Relieves the discomfort of your dry mouth</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Dry Mouth</condition>
  <arm_group>
    <arm_group_label>Marketed Mouth Rinse</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dry mouth rinse to be taken up to 5x a day, at least twice a day, 15 ml for 30 seconds. Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after first use (on-site) on Day 1 and Day 4.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental Mouth Rinse</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dry mouth rinse to be taken up to 5x a day, at least twice a day, 15 ml for 30 seconds. Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after first use (on-site) on Day 1 and Day 4.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water/Negative Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>subjects will swallow 15 ml of water (on-site). Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after water intake (on-site) on Day 1 and Day 4.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Marketed Dry Mouth Rinse</intervention_name>
    <description>relieves dry mouth symptoms by physically coating oral mucosal surfaces.</description>
    <arm_group_label>Marketed Mouth Rinse</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water control</intervention_name>
    <description>negative control</description>
    <arm_group_label>Water/Negative Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Experimental Dry Mouth Rinse</intervention_name>
    <description>relieves dry mouth symptoms by physically coating oral mucosal surfaces.</description>
    <arm_group_label>Experimental Mouth Rinse</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provide written informed consent prior to participation and be given a signed copy of&#xD;
             the informed consent form;&#xD;
&#xD;
          -  Be at least 18 years of age;&#xD;
&#xD;
          -  Be in good general health as determined by the Investigator/designee;&#xD;
&#xD;
          -  Agree not to participate in any other oral care studies for the duration of this&#xD;
             study;&#xD;
&#xD;
          -  Agree to delay elective dentistry, including dental prophylaxis, until study&#xD;
             completion, and to report any non-study dentistry received during the course of the&#xD;
             study;&#xD;
&#xD;
          -  Agree to refrain from the use of any non-study oral hygiene products for the study&#xD;
             duration including mouth rinse and toothpaste (flossing is permitted if part of their&#xD;
             normal routine);&#xD;
&#xD;
          -  Self-report a dry mouth feeling according to the modified DMI questions. (Subject must&#xD;
             answer at least 2 out of 4 questions with 'agree a little,' 'agree' or 'strongly&#xD;
             agree');&#xD;
&#xD;
          -  Agree to refrain from smoking, drinking, using tobacco products, using breath mints,&#xD;
             medicated lozenges, or chewing gum during the 4-hour test period;&#xD;
&#xD;
          -  Agree to return for all scheduled visits and to follow all study procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any condition or disease, as determined by the Investigator/Designee, that could be&#xD;
             expected to interfere with examination procedures, with compliance, or with the&#xD;
             subject's safe completion of the study;&#xD;
&#xD;
          -  Severe periodontal disease, as characterized by purulent exudate, generalized&#xD;
             mobility, and/or severe recession;&#xD;
&#xD;
          -  Active treatment for periodontitis;&#xD;
&#xD;
          -  Having a history of allergies or hypersensitivity to mouth rinse or ingredients in&#xD;
             commercial dental products or cosmetics;&#xD;
&#xD;
          -  Self-reported pregnancy or the intent to become pregnant during the study, or breast&#xD;
             feeding;&#xD;
&#xD;
          -  Full or partial dentures or any orthodontic appliances such as braces or aligners, or&#xD;
             tongue or mouth piercing;&#xD;
&#xD;
          -  Having diabetes;&#xD;
&#xD;
          -  Inability to undergo any study procedure;&#xD;
&#xD;
          -  Having untreated oral mucosal disease which in the opinion of the investigator could&#xD;
             interfere with the study (e.g., current oral ulceration);&#xD;
&#xD;
          -  Use of prescription systemic parasympathetic medications (e.g., Pilocarpine), for the&#xD;
             treatment of the feeling of dry mouth;&#xD;
&#xD;
          -  Currently under the care of a dental/medical professional specifically for the&#xD;
             treatment of dry mouth (at the discretion of the Investigator/Designee);&#xD;
&#xD;
          -  Self-reported mouth breathers (i.e., mouth breathing secondary to nasal obstruction);&#xD;
&#xD;
          -  Evidence of gross intra-oral neglect or need for extensive dental therapy; or&#xD;
&#xD;
          -  Currently undergoing radiotherapy and/or chemotherapy treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malgorzata Klukowska, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Procter and Gamble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Procter &amp; Gamble</name>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 1, 2019</study_first_submitted>
  <study_first_submitted_qc>November 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2019</study_first_posted>
  <results_first_submitted>November 9, 2020</results_first_submitted>
  <results_first_submitted_qc>January 13, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 2, 2021</results_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Xerostomia</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 10, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT04152642/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Subjects that qualified were randomized to one of six treatment sequences: ABC, ACB, BCA, BAC, CAB, or CBA. Subjects had at least a 3 day washout before Period 1 and in-between each period.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Overall Study</title>
          <description>Single-center, randomized 3-treatment, 3-periods cross-over study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>C (Water/Negative) Control</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>A (Marketed Rinse)</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>B (Experimental Rinse)</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>single-center, randomized 3-treatment, 3-period crossover study</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.3" spread="11.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Dry Mouth Inventory</title>
          <description>subjects had to answer 2 of the 4 dry mouth inventory questions positively. How much do you agree or disagree that you experience the following? (strongly disagree, disagree, disagree a little, agree a little, agree, strongly agree)&#xD;
No moisture in the mouth&#xD;
Lips sticking to teeth&#xD;
Tongue sticking to roof of mouth&#xD;
Throat feels dry</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>No moisture in the mouth</title>
              <category_list>
                <category>
                  <title>Agree a Little, Agree, or Strongly Agree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Disagree a Little, Disagree, or Strongly Disagree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lips sticking to teeth</title>
              <category_list>
                <category>
                  <title>Agree a Little, Agree, or Strongly Agree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Disagree a Little, Disagree, or Strongly Disagree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tongue sticking to roof of mouth</title>
              <category_list>
                <category>
                  <title>Agree a Little, Agree, or Strongly Agree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Disagree a Little, Disagree, or Strongly Disagree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Throat feels dry</title>
              <category_list>
                <category>
                  <title>Agree a Little, Agree, or Strongly Agree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Disagree a Little, Disagree, or Strongly Disagree</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Product Performance and Attributes (PPAQ I) Question #1: 2-hr at Day 4</title>
        <description>Product Performance and Attributes (PPAQ I) Question #1:&#xD;
Since you have been used the product, please rate each of the following at this timepoint: (Select one response for each attribute)- excellent=5, very good=4, good=3, fair=2, poor=1:&#xD;
1) Relieves the discomfort of your dry mouth</description>
        <time_frame>2-hour, Day 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Water/Negative Control</title>
            <description>subjects will swallow 15 ml of water (on-site). Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after water intake (on-site) on Day 1 and Day 4.&#xD;
Water control: negative control</description>
          </group>
          <group group_id="O2">
            <title>Marketed Mouth Rinse</title>
            <description>dry mouth rinse to be taken up to 5x a day, at least twice a day, 15 ml for 30 seconds. Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after first use (on-site) on Day 1 and Day 4.&#xD;
Marketed Dry Mouth Rinse: relieves dry mouth symptoms by physically coating oral mucosal surfaces.</description>
          </group>
          <group group_id="O3">
            <title>Experimental Mouth Rinse</title>
            <description>dry mouth rinse to be taken up to 5x a day, at least twice a day, 15 ml for 30 seconds. Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after first use (on-site) on Day 1 and Day 4.&#xD;
Experimental Dry Mouth Rinse: relieves dry mouth symptoms by physically coating oral mucosal surfaces.</description>
          </group>
        </group_list>
        <measure>
          <title>Product Performance and Attributes (PPAQ I) Question #1: 2-hr at Day 4</title>
          <description>Product Performance and Attributes (PPAQ I) Question #1:&#xD;
Since you have been used the product, please rate each of the following at this timepoint: (Select one response for each attribute)- excellent=5, very good=4, good=3, fair=2, poor=1:&#xD;
1) Relieves the discomfort of your dry mouth</description>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.79" spread="0.197"/>
                    <measurement group_id="O2" value="2.97" spread="0.204"/>
                    <measurement group_id="O3" value="3.33" spread="0.203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected for the entire duration of the study for each intervention, an average of 1 month.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Water/Negative Control</title>
          <description>subjects will swallow 15 ml of water (on-site). Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after water intake (on-site) on Day 1 and Day 4.&#xD;
Water control: negative control</description>
        </group>
        <group group_id="E2">
          <title>Marketed Mouth Rinse</title>
          <description>dry mouth rinse to be taken up to 5x a day, at least twice a day, 15 ml for 30 seconds. Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after first use (on-site) on Day 1 and Day 4.&#xD;
Marketed Dry Mouth Rinse: relieves dry mouth symptoms by physically coating oral mucosal surfaces.</description>
        </group>
        <group group_id="E3">
          <title>Experimental Mouth Rinse</title>
          <description>dry mouth rinse to be taken up to 5x a day, at least twice a day, 15 ml for 30 seconds. Subjects will be restricted from using mouth rinse, acclimation products, eating or drinking for 4-hours after first use (on-site) on Day 1 and Day 4.&#xD;
Experimental Dry Mouth Rinse: relieves dry mouth symptoms by physically coating oral mucosal surfaces.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Gingival Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
              <event>
                <sub_title>Mouth Ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>mouth injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Trial Manager</name_or_title>
      <organization>Procter &amp; Gamble</organization>
      <phone>5136225362</phone>
      <email>combs.cs@pg.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

